Additional Proxy Soliciting Materials (definitive) (defa14a)
April 22 2022 - 04:34PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No.)
Filed by the Registrant |
x |
Filed by a Party other than the Registrant |
¨ |
Check the appropriate box: |
|
¨ |
Preliminary Proxy Statement |
¨ |
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2)) |
¨ |
Definitive Proxy Statement |
x |
Definitive Additional Materials |
¨ |
Soliciting Material under §240.14a-12 |
CYTOSORBENTS CORPORATION
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the
Registrant)
Payment of Filing Fee (Check the appropriate box):
x |
No fee required |
¨ |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11. |
¨ |
Fee paid previously with preliminary materials. |

|
Your Vote Counts!
CYTOSORBENTS CORPORATION C/O BROADRIDGE P.O. BOX 1342 BRENTWOOD, NY
11717 CYTOSORBENTS CORPORATION 2022 Annual Meeting Vote by June 6,
2022 11:59 PM ET You invested in CYTOSORBENTS CORPORATION and it’s
time to vote! You have the right to vote on proposals being
presented at the Annual Meeting. This is an important notice
regarding the availability of proxy material for the stockholder
meeting to be held on June 7, 2022. Vote Virtually at the Meeting*
June 7, 2022 10:00 a.m., Eastern time Virtually at:
www.virtualshareholdermeeting.com/CTSO2022 *Please check the
meeting materials for any special requirements for meeting
attendance. Smartphone users Point your camera here and vote
without entering a control number V1.1 For complete information and
to vote, visit www.ProxyVote.com Control # D78619-P70391 Get
informed before you vote View the Notice and Proxy Statement and
Annual Report online OR you can receive a free paper or email copy
of the material(s) by requesting prior to May 24, 2022. If you
would like to request a copy of the material(s) for this and/or
future stockholder meetings, you may (1) visit www.ProxyVote.com,
(2) call 1-800-579-1639 or (3) send an email to
sendmaterial@proxyvote.com. If sending an email, please include
your control number (indicated below) in the subject line. Unless
requested, you will not otherwise receive a paper or email
copy.
|
+
|
THIS IS NOT A
VOTABLE BALLOT This is an overview of the proposals being presented
at the upcoming stockholder meeting. Please follow the instructions
on the reverse side to vote these important matters. Vote at
www.ProxyVote.com Prefer to receive an email instead? While voting
on www.ProxyVote.com, be sure to click “Sign up for E-delivery”.
Voting Items Board Recommends D78620-P70391 1. To elect the
following nominees to serve as directors: Nominees: 1d. Michael G.
Bator, MBA 1a. Phillip P. Chan, MD, PhD 1b. Al W. Kraus 1e. Alan D.
Sobel, CPA 1c. Edward R. Jones, MD, MBA 1f. Jiny Kim, MBA 2. To
approve, on an advisory basis, the compensation of the Company’s
named executive officers, disclosed pursuant to Item 402 of
Regulation S-K. 3. To ratify the appointment of WithumSmith+Brown,
PC as CytoSorbents Corporation’s independent auditors to audit
CytoSorbents Corporation’s financial statements for the fiscal year
ending December 31, 2022. 4. To conduct such other business as may
properly come before the Annual Meeting or any adjournments
thereof. For For For For For For For For
|
CytoSorbents (NASDAQ:CTSO)
Historical Stock Chart
From May 2022 to Jun 2022
CytoSorbents (NASDAQ:CTSO)
Historical Stock Chart
From Jun 2021 to Jun 2022